Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis

被引:22
|
作者
Laura Alberti, Maria [1 ]
Malet Ruiz, Jose Maria [1 ]
Eduardo Fernandez, Martin [1 ]
Fassola, Leandro [1 ]
Caro, Fabian [1 ]
Buendia Roldan, Ivette [2 ]
Paulin, Francisco [1 ]
机构
[1] Hosp Maria Ferrer Buenos Aires, Interstitial Lung Dis Clin, Buenos Aires, DF, Argentina
[2] Inst Nacl Enfermedades Resp INER Ismael Cosio Vil, Buenos Aires, DF, Argentina
来源
PULMONOLOGY | 2020年 / 26卷 / 01期
关键词
Chronic hypersensitivity pneumonitis; Idiopathic pulmonary fibrosis; Extrinsic allergic alveolitis; Interstitial lung disease; INTERSTITIAL PNEUMONIA; CT FINDINGS; DIAGNOSIS; AZATHIOPRINE;
D O I
10.1016/j.pulmoe.2019.08.007
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Introduction: Chronic hypersensitivity pneumonitis (CHP) is an interstitial lung disease with limited treatment response and bad prognosis. Sometimes it is indistinguishable from idiopathic pulmonary fibrosis (IPF) becoming one of the main differential diagnosis. The aim of our study is to compare survival and functional decline between these two entities. Methods: Survival and functional decline more than 10% in FVC were compared using Kaplan Meier (KM) method between patients with CHP and IPF. Cox proportional hazard analysis was used to identify independent predictors of survival and functional decline. Results: 146 patients were included, 54 with CHP and 92 with IPF. KM rate for 2 years survival was 0.71 (CI 95% 0,6-0,8) for CHP group and 0,83 (CI 95% 0,66 - 0,92) for IPF (p = 0,027). Nevertheless this difference disappeared using Cox proportional hazard analysis, the adjusted HR for survival among CHP patients was 0,53 (CI 95% 0,25-1,15) (p = 0,11). There was no difference in functional evolution between the two groups. KM rate for a decline more than or equal to 10% was 0,64 for CHP (CI 95% 0,43-0,79) and 0,78 for IPF (IC 95% 0,6-0,88) (p = 0,22). This observation did not change after using Cox proportional hazard analysis. Conclusions: Our study shows that both IPF and CHP are fibrosing interstitial diseases with a similar evolution and survival. It might be possible that therapeutic approach in patients with CHP should change in the light of these observations. (C) 2019 Sociedade Portuguesa de Pneumologia. Published by Elsevier Espana, S.L.U.
引用
收藏
页码:3 / 9
页数:7
相关论文
共 50 条
  • [1] Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis: Retrospective cohort study.
    Laura Alberti, Maria
    Eduardo Fernandez, Martin
    Fassola, Leandro
    Caro, Fabian
    Paulin, Francisco
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [2] UIP PATTERN OF CHRONIC HYPERSENSITIVITY PNEUMONITIS: DIFFERENTIATION FROM IDIOPATHIC PULMONARY FIBROSIS
    Tateishi, Tomoya
    Johkoh, Takeshi
    Sakai, Fumikazu
    Miyazaki, Yasunari
    Ogura, Takashi
    Ichikado, Kazuya
    Chida, Kingo
    Taguchi, Yoshio
    Inoue, Yoshikazu
    Takemura, Tamiko
    Colby, Thomas V.
    Sumikawa, Hiromitsu
    Fujimoto, Kiminori
    Arakawa, Hiroaki
    Inase, Naohiko
    RESPIROLOGY, 2013, 18 : 138 - 138
  • [3] The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis
    Invernizzi, Rachele
    Wu, Benjamin G.
    Barnett, Joseph
    Ghai, Poonam
    Kingston, Shaun
    Hewitt, Richard J.
    Feary, Johanna
    Li, Yonghua
    Chua, Felix
    Wu, Zhe
    Wells, Athol U.
    George, Peter M.
    Renzoni, Elisabetta A.
    Nicholson, Andrew G.
    Rice, Alexandra
    Devaraj, Anand
    Segal, Leopoldo N.
    Byrne, Adam J.
    Maher, Toby M.
    Lloyd, Clare M.
    Molyneaux, Philip L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (03) : 339 - 347
  • [4] Uip Pattern Of Chronic Hypersensitivity Pneumonitis: Differentiation From Idiopathic Pulmonary Fibrosis
    Tateishi, T.
    Johkoh, T.
    Sakai, F.
    Miyazaki, Y.
    Ogura, T.
    Ichikado, K.
    Suda, T.
    Taguchi, Y.
    Inoue, Y.
    Takemura, T.
    Colby, T. V.
    Sumikawa, H.
    Fujimoto, K.
    Arakawa, H.
    Inase, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [5] A MULTICENTRE RETROSPECTIVE COHORT COMPARISON OF AETIOLOGY AND SURVIVAL IN PATIENTS WITH CHRONIC HYPERSENSITIVITY PNEUMONITIS VERSUS IDIOPATHIC PULMONARY FIBROSIS
    Barratt, S. L.
    Adamali, H. I.
    Creamer, A.
    Duckworth, A.
    Fallon, J.
    Gibbons, M. A.
    Gooptu, B.
    Nancarrow, T.
    Pepperell, J.
    Spiers, A. S.
    Stone, R. A.
    Wollerton, R. L.
    Woodhead, F. A.
    Scotton, C. J.
    THORAX, 2018, 73 : A190 - A190
  • [6] The Pathogenesis of Chronic Hypersensitivity Pneumonitis in Common With Idiopathic Pulmonary Fibrosis Expression of Apoptotic Markers
    Jinta, Torahiko
    Miyazaki, Yasunari
    Kishi, Masato
    Akashi, Takumi
    Takemura, Tamiko
    Inase, Naohiko
    Yoshizawa, Yasuyuki
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (04) : 613 - 620
  • [7] Severity of Sleep Disordered Breathing in Patients with Idiopathic Pulmonary Fibrosis and Chronic Hypersensitivity Pneumonitis
    Abdullah, R.
    Kent-Bramer, J.
    Renzoni, E. A.
    Kouranos, V.
    Chua, F. J.
    Kokosi, M.
    Wells, A. U.
    Maher, T. M.
    Man, W.
    Molyneaux, P. L.
    Polkey, M. I.
    George, P. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [8] Chronic Summer-type Hypersensitivity Pneumonitis: clinical similarities to idiopathic pulmonary fibrosis
    Inase, Naohiko
    Ohtani, Yoshio
    Usui, Yutaka
    Miyazaki, Yasunari
    Takemura, Tamiko
    Yoshizawa, Yasuyuki
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2007, 24 (02) : 141 - 147
  • [9] Pathogenesis of chronic hypersensitivity pneumonitis (HP) - differences and similarities to idiopathic pulmonary fibrosis (IPF)
    Wygrecka, M.
    Wujak, L.
    Markart, P.
    ALLERGOLOGIE, 2017, 40 (07) : 268 - 272
  • [10] The effect of pulmonary fibrosis on survival in patients with hypersensitivity pneumonitis
    Vourlekis, JS
    Schwarz, MI
    Cherniack, RM
    Curran-Everett, D
    Cool, CD
    Tuder, RM
    King, TE
    Brown, KK
    AMERICAN JOURNAL OF MEDICINE, 2004, 116 (10): : 662 - 668